◄ back to all posts
Financial data and stock pages provided by
Fintel.io
RIOT: Riot Blockchain Inc Stock
Written by | Jul 6, 2018
Print FriendlySIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 39.10 |
| Enterprise Value ($M) | 23.97 |
| Book Value ($M) | 26.10 |
| Book Value / Share | 1.11 |
| Price / Book | 1.53 |
| NCAV ($M) | 13.54 |
| NCAV / Share | 0.57 |
| Price / NCAV | 2.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -10.40 |
| Return on Assets (ROA) | -1.15 |
| Return on Equity (ROE) | -1.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | 4.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 18.37 |
| Assets | 30.97 |
| Liabilities | 4.83 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.85 |
| Operating Income | -59.37 |
| Net Income | -60.21 |
| Earnings Per Share Basic And Diluted | -4.33 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -19.05 |
| Cash from Investing | -24.86 |
| Cash from Financing | -24.86 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Calc Iii Lp | 4.40 | ||
| 13G/A | Susquehanna Securities | 3.00 | ||
| 13G/A | Hudson Bay Capital Management LP | 2.25 | ||
| 13D/A | Honig Barry C | 1.69 | 0.00 | |
| 13G/A | Northurst Inc. | 9.27 | ||
| 13G/A | Groussman Mark | 1.62 | ||
| 13G/A | Honig Jonathan | 1.71 | -68.54 | |
| 13G/A | Peierls E Jeffrey | 12.00 | ||
| 13G/A | Remeditex Ventures LLC | 0.00 | -100.00 | |
| 13D/A | DeFrancesco Catherine Johanna DeFrancesco | 11.45 | 7.84 | |
| 13D/A | Mgt Capital Investments Inc | 2.12 | -92.64 | |
| 13G/A | Perkins Capital Management Inc | 2.90 | 101.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 141,195 | 426,700 | 33.09 | |
| 97,883 | 384,400 | 25.46 | |
| 40,149 | 178,500 | 22.49 | |
| 62,187 | 271,300 | 22.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RGLS – Regulus Therapeutics Inc. | RGNX – REGENXBIO Inc. |
| RIGL – Rigel Pharmaceuticals, Inc. | RLMD – Relmada Therapeutics, Inc. |
| RLYP – Relypsa, Inc. |
Financial data and stock pages provided by
Fintel.io
